[Peripheral blood changes infections and supportive care under intensive chemotherapy for solid tumors CT2 and T6 protocol) (author's transl)].
Two combination chemotherapy protocols are compared for their toxicity. As expected the T6 protocol is more toxic to the bone marrow when compared to the T2 protocol. The incidence of blood transfusions is increased two to three fold. There is no increased incidence of other severe side effects or acute complications. Both chemotherapy protocols are tolerable if intensive supportive care including platelet transfusions can be provided.
D000293:Adolescent; D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001424:Bacterial Infections / Q000188:drug therapy / Q000209:etiology; D001803:Blood Transfusion; D001853:Bone Marrow / Q000187:drug effects; D002648:Child; D002675:Child, Preschool; D004359:Drug Therapy, Combination; D006801:Humans; D007223:Infant; D007680:Kidney Neoplasms / Q000188:drug therapy; D008722:Methods; D009369:Neoplasms / Q000188:drug therapy*; D012208:Rhabdomyosarcoma / Q000188:drug therapy; D012512:Sarcoma, Ewing / Q000188:drug therapy; D018805:Sepsis / Q000188:drug therapy / Q000209:etiology; D013724:Teratoma / Q000188:drug therapy; D009396:Wilms Tumor / Q000188:drug therapy
D000970:Antineoplastic Agents
Blutbild, Infektionen und supportive Therapie während der Chemotherapie solider Tumoren nach dem T2 und T6-Protokoll.